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doi:10.1016/j.kjms.2011.06.035Abstract Cancer polyarthritis is an uncommon, paraneoplastic manifestation of some solid
and hematological malignancies. Herein, we report the case of a 55-year-old woman who
recently experienced polyarthritis for 2 months. On admission, the patient developed cough,
expectoration, and fever. According to the clinical manifestations and the findings in radiolog-
ical examinations and sputum cultures, pneumonia was considered. No evidence of lung cancer
was noted by repeated computed tomography scan of lung, single bronchoscopy, or computed
tomographyeguided lung biopsy. Ultimately, the second bronchoscopy with biopsy was carried
out, and lung adenocarcinoma was confirmed by pathological examination. Symptoms of poly-
arthritis starting 2 months before the symptoms of her lung cancer in the present case leads us
to believe that polyarthritis may be a manifestation of paraneoplastic syndrome. Arthritis
resolved after anticancer therapy. Our report indicates that polyarthritis of unknown cause
may be suspected as a manifestation of malignancies.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Neoplasms may present characteristics of rheumatic disor-
ders [1]. Some of the rheumatological manifestations may
result from direct cancer invasion or metastasis into bone
and joints, which are occasionally absent in some cases [2].of General Practice, Sir Run
e, Zhejiang University, No. 3
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vier Taiwan LLC. All rights reservPolyarthritis is a common disease but polyarthritis as
a primary manifestation is relatively rare in malignancies. In
this case, we report about a Chinese woman who recently
experienced polyarthritis for 2 months, and finally, lung
cancer was diagnosed. Our report may be helpful for timely
diagnosis and treatment of occult cancers.
Case presentation
In November 2009, a 55-year-old woman came to our
outpatient clinic with the complaint of gradually worseninged.
Figure 1. Chest computed tomography showed inflammation
in the anterior segment of bilateral upper lobes.
Polyarthritis and occult lung cancer 55polyarthritis for 2 months. Two months earlier, she pre-
sented with right knee pain. Three days later, the pain was
also felt in her right shoulder, with subsequent involvement
of her wrists, bilateral metacarpophalangeal joints (MCP),
and elbows. Swellings of bilateral MCPs and wrists occurred
several days later. Symptoms did not improve after activity
or rest. No joint stiffness, subcutaneous nodules, respira-
tory symptoms, or fever was presented. She also denied
diarrhea, frequent urination, or dysuria before the joint
pain. In other hospitals, laboratory examinations of rheu-
matoid factor (RF), antinuclear antibodies, uric acid, HLA-
B27, immunoglobulin, and complements showed normal
results, and symptoms were not alleviated after adminis-
tration of nonsteroidal anti-inflammatory drugs. She lost
appetite and weight of 5 kg in 2 months. The patient was
a nonsmoker and never consumed alcohol. There was no
history of rheumatic diseases in her family members.
On admission, physical examination, including those of
skin, nails, fingers, toes, and genitals, revealed normal
results except tenderness and swelling of bilateral MCPs
and wrists, and pretibial tenderness was not found. Labo-
ratory examinations revealed the following: erythrocyte
sedimentation rate, 44 mm/hr (range, 1e20 mm/hr);
immunoglobulin G, 1,970 mg/dL (range, 694e1,620 mg/
dL); carcinoma embryonic antigen (CEA), 11.96 ng/mL
(range, 0e5 ng/mL); and ferritin, greater than 2,000 mg/L
(range, 13e150 mg/L). RF, HLA-B27, antinuclear antibodies,
anti-streptolysin O, high-sensitivity C-reactive protein,
blood cell count, and kidney and liver function parameters
were all within normal ranges. Magnetic resonance imaging
of right knee indicated the degeneration of posterior horn
of the meniscus. Radiographic examination of both hands
showed normal results, and periosteum hypertrophy of the
distal part of ulna and radius was not detected. Chest X-ray
showed increased pulmonary markings with a suspicious
nodule in the right upper lung. Computed tomography (CT)
of the lung documented inflammation in the lingular
segment of left lung and subpleural pneumonia.
Connective tissue diseases were suspected, and the
patient was treated with diclofenac diethylamine emulgel
(Beijing Novartis Company, China), but the pain or swelling
of the joints did not resolve. On the fourth day of admis-
sion, the patient complained of cough with sputum. Fine
moist rales were heard at bilateral lower lobes. According
to the clinical manifestations and the findings on imaging,
pneumonia was considered. She was treated with intrave-
nous infusion of cefuroxime (GlaxoSmithKline S.p.A., Italy)
(1.5 g, twice a day (bid)) and ambroxol tablet (Boehringer
Ingelheim Corporate, German) (30 mg, three times a day
(tid)). Despite 7 days of antibiotic treatment, cough and
expectoration persisted, and the patient developed a fever
of 38.5C. Chest CT showed inflammation in the right upper
and middle lobes and the left upper and lower lobes,
a small amount of bilateral pleural effusion and mediastinal
lymph node enlargement (Fig. 1). Bronchoscopy revealed
no abnormalities. The laboratory findings were as follows:
leukocyte count, 4.2/nL (range, 4.0e10.0/nL); neutrophils,
77.7% (range, 55e75%); C-reactive protein, 8.71 mg/L
(range, 0e5 mg/L); and erythrocyte sedimentation rate,
53 mm/hr. The patient was treated with intravenous infu-
sion of imipenem (Merck & Co., inc., U.S.A) (0.5 g, every 8
hours) because of the positivity for Acinetobactercalcoaceticus-baumannii in sputum culture. The patient’s
body temperature returned to normal 1 week later, but she
developed chest tightness and shortness of breath on
exercise. Chest CT showed that the lesions in the right lung
were improved, but those in the left lung remained. Left
lung biopsy was carried out under the guidance of CT, and
the inflammatory lesion was confirmed. Because the
symptoms were not relieved significantly, the patient was
treated with intravenous infusion of voriconazole (Pfizer
Ireland Pharmaceuticals Limited, Ireland) (200 mg, bid) for
10 days according to the sputum smears positive for fungi.
However, the patient’s condition worsened and joint pain
progressed, and it was more serious than before. Then, the
fourth thoracic CT was performed, and progression of
lesions in the left lung was indicated. Furthermore, serum
CEA was elevated to 23.37 ng/mL. The second bronchos-
copy also revealed no neoplasm in the bronchus. Bronchial
brushing cytology showed negative result for malignancy.
Ultimately, the patient was diagnosed with adenocarci-
noma in the left lung according to pathological examination
by second bronchoscopy with biopsy (Fig. 2).
Emission CT was performed, and no osseous metastasis
was detected. After treatment with gefitinib tablet
(AatraZeneca Pharmaceuticals, England) (250 mg, once
a day (qd)), cough, chest tightness, and shortness of breath
were improved significantly, and the pain and swelling of
the joints alleviated accordingly.
Discussion
The causes of cancer-associated rheumatic disorders can be
classified as follows [3]: direct invasion by cancer; para-
neoplastic syndromes; altered immune surveillance,
resulting in both the rheumatic and the neoplastic diseases;
and adverse effects of anticancer therapy. Paraneoplastic
rheumatic disorders are those cancer-associated rheumatic
syndromes occurring at a distance from the primary cancer
site or as a result of metastasis and are mediated by
humoral factors (hormones or cytokines) excreted by tumor
cells or by an immune response against the tumor. Poly-
arthritis can be a manifestation of paraneoplastic syndrome
and is associated with various malignancies.
Cancer polyarthritis is an uncommon clinical entity, but
its recognition is of clinical importance because its
Figure 2. Hematoxylin and eosin staining and light micros-
copy of lung tissue. Cancer cells were arranged in solid nests or
cords, and a fraction of cancer cells showed a tubule-like
growth pattern. The cancer cells were atypical with frequent
mitotic figures. (A) 100; (B) 400.
56 Y.-M. Han et al.appearance may be a prewarning sign of occult neoplasia,
just as in the present case. Therefore, if appreciated, it
may allow earlier cancer detection; if unrecognized, it may
lead to misdiagnosis and poor prognosis.
The clinical features of the present patient illustrate
a few interesting points. The patient initially presented
with polyarthritis, but was free of respiratory symptoms.
Subsequently, this patient developed cough, expectora-
tion, and fever, and pneumonia was considered. No
evidence of lung cancer was demonstrated by repeated CT
scan, bronchoscopy, and lung biopsy. Progression of symp-
toms even after anti-infection treatment and findings on
imaging made the diagnosis of pneumonia uncertain. Thus,
bronchoscopy was carried out again, and lung adenocarci-
noma was confirmed by the pathological examination. It
indicates that a malignancy may be suspected when poly-
arthritis of unknown cause is present, even in the absence
of common manifestations of malignancies.
Symptoms of polyarthritis started 2 months before the
symptoms of her lung cancer in the present case, which led
us to believe that polyarthritis may be a manifestation ofparaneoplastic syndrome. The present case is consistent
with the findings that cancer polyarthritis is characterized
by the late onset of disease, explosive nature of arthrop-
athy, severity of pain disproportionate to physical findings,
absence of RF or rheumatoid nodules, no family history of
rheumatoid arthritis, and absence of lesions on radiography
[4,5].
In our case, the involvement of bilateral wrist and MCP
joints of hands was noted. Further examinations estab-
lished the diagnosis of lung adenocarcinoma, and the
polyarthritis was considered as a presentation of para-
neoplastic syndrome. The fact that arthritis resolved
significantly after anticancer therapy further confirmed
the diagnosis of cancer polyarthritis.
In the present case, weight loss was complained of.
Systemic symptoms may be early manifestations of occult
neoplasia, and the cause of systemic symptoms should be
identified, which may be beneficial for the identification of
underlying malignancies.
CEA is one of the tumor markers. In our case, CEA was
elevated before the respiratorymanifestations and increased
gradually. Finally, lung adenocarcinoma was detected.
Cancer polyarthritis may develop before the occurrence of
obvious symptoms of malignancies [6]; thus, arthropathy of
unknown cause accompaniedwith increased CEA level should
be suspected as cancer polyarthritis, and related cancers
should be screened. Thereafter, close follow-up is necessary
to exclude or confirm the diagnosis of malignancies, espe-
cially when the CEA level increased gradually.
In conclusion, cancer polyarthritis is a relatively rare
phenomenon, to which one needs to pay enough attention.
Cancer polyarthritis should be considered in patients pre-
senting polyarthritis of uncertain cause, and sometimes,
repeated examinations are necessary. Furthermore, the
clinical course of a paraneoplastic syndrome usually
parallels with the progression of the malignancy. Once the
association between a malignancy and a paraneoplastic
syndrome is identified, reappearance of symptoms can be
used to monitor cancer recurrence at an early stage [7].
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